Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4).
説明 | JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor β (PDGFR-β), and ephrin type-B receptor 4 (EphB4). |
別名 | CGI-1842, JI 101 |
分子量 | 466.33 |
分子式 | C22H20BrN5O2 |
CAS No. | 900573-88-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (58.97 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JI-101 900573-88-8 Angiogenesis Tyrosine Kinase/Adaptors VEGFR Ephrin Receptor PDGFR Inhibitor Vascular endothelial growth factor receptor CGI1842 CGI-1842 JI 101 Platelet-derived growth factor receptor JI101 CGI 1842 inhibit inhibitor